"CRISPR for Disabilities: How to Self-Regulate" or Something?

Area of Science:

• Biotechnology
• Genetics
• Bioethics

Background:

• CRISPR gene editing is presented as a revolutionary technology for research and clinical applications.
• Previous technologies like gene therapy and stem cell research faced similar hype, leading to premature clinical translation and adverse outcomes.
• The rapid progression from basic research to clinical application requires careful evaluation.

Purpose of the Study:

• To critically assess the scientific hype surrounding CRISPR gene editing technology.
• To define the ethical and practical issues concerning CRISPR/Cas systems in basic research, particularly regarding disabilities.
• To propose a decision-making framework for the judicious application of CRISPR technology.

Main Methods:

• Literature review of CRISPR gene editing, gene therapy, and stem cell research.
• Analysis of potential impacts of CRISPR on single-gene versus complex diseases.
• Examination of CRISPR's implications for individuals with disabilities and societal discourse.
• Development of a decision tree for technology utilization.

Main Results:

• CRISPR, like prior hyped technologies, may face challenges in clinical translation.
• Application in complex diseases and disabilities poses risks of negative impacts and toxicity.
• Genetic complexity in common disabilities may limit CRISPR's efficacy and exacerbate social devaluation.

Conclusions:

• A cautious approach to CRISPR clinical application is warranted, prioritizing basic research and ethical considerations.
• CRISPR's utility in complex genetic conditions and disabilities requires further investigation to avoid unintended harm.
• Alternative research funding strategies should be explored to ensure optimal resource allocation beyond potentially ineffective technological solutions.